Semaglutide is redefining how we manage type 2 diabetes, tackle obesity, and protect cardiovascular health. This innovative medication belongs to a class known as GLP-1 receptor agonists, which are designed to mimic the naturally occurring GLP-1 (glucagon-like peptide-1) hormone. The GLP-1 hormone plays a vital role in regulating blood sugar https://messiahdinsw.bloggactivo.com/30447423/semaglutide-a-game-changing-treatment-for-weight-loss-diabetes-and-cardiovascular-health